Literature DB >> 17826070

Breast tattoos for planning surgery following neoadjuvant chemotherapy.

Donald R Lannin1, Baiba Grube, D Shon Black, Teresa Ponn.   

Abstract

BACKGROUND: Although neoadjuvant chemotherapy is increasingly used for breast cancer, if a patient has a complete clinical response, it is often difficult for the surgeon to know exactly where and how much breast tissue to remove.
METHODS: A method is described where the edges of the tumor are tattooed prior to chemotherapy, allowing all tissue initially involved with tumor to be resected following the chemotherapy.
RESULTS: Thirty-four cases have been tattooed prior to neoadjuvant chemotherapy, and the clinical and pathological complete response rates were 56% and 22%, respectively. The tattoos allowed very accurate localization of the residual tumor location and extent. Of the 22 patients who have so far undergone lumpectomy, 77% had residual pathologic evidence of tumor, but the margins were negative in 91% at the first operation. Only 2 patients had to undergo a mastectomy because of persistently positive margins.
CONCLUSIONS: The technique of breast tattooing is a simple and practical method to guide the extent of breast surgery following neoadjuvant chemotherapy. In contrast to placement of clips, the technique does not require needle localization, and it allows accurate determination of the initial tumor size and margins.

Entities:  

Mesh:

Year:  2007        PMID: 17826070     DOI: 10.1016/j.amjsurg.2007.07.009

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

Review 1.  Does Tumor Marking Before Neoadjuvant Chemotherapy Helps Achieve Better Outcomes in Patients Undergoing Breast Conservative Surgery? A Systematic Review.

Authors:  Chandan Kumar Jha; Goonj Johri; Prashant Kumar Singh; Sanjay Kumar Yadav; Upasna Sinha
Journal:  Indian J Surg Oncol       Date:  2021-08-03

2.  "No Ink on Tumor" in Breast-Conserving Surgery after Neoadjuvant Chemotherapy.

Authors:  Giulia Atzori; Marco Gipponi; Chiara Cornacchia; Raquel Diaz; Marco Sparavigna; Maurizio Gallo; Tommaso Ruelle; Federica Murelli; Simonetta Franchelli; Francesca Depaoli; Daniele Friedman; Piero Fregatti
Journal:  J Pers Med       Date:  2022-06-23

3.  Guidelines for locoregional therapy in primary breast cancer in developing countries: The results of an expert panel at the 8(th) Annual Women's Cancer Initiative - Tata Memorial Hospital (WCI-TMH) Conference.

Authors:  Anusheel Munshi; Sudeep Gupta; Benjamin Anderson; John Yarnold; Vani Parmar; Rakesh Jalali; Suresh Chander Sharma; Sangeeta Desai; Meenakshi Thakur; Gunjan Baijal; Rajiv Sarin; Indraneel Mittra; Jaya Ghosh; Rajendra Badwe
Journal:  Indian J Med Paediatr Oncol       Date:  2012-04

4.  Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.

Authors:  Valentina Iotti; Sara Ravaioli; Rita Vacondio; Chiara Coriani; Sabrina Caffarri; Roberto Sghedoni; Andrea Nitrosi; Moira Ragazzi; Elisa Gasparini; Cristina Masini; Giancarlo Bisagni; Giuseppe Falco; Guglielmo Ferrari; Luca Braglia; Alberto Del Prato; Ivana Malavolti; Vladimiro Ginocchi; Pierpaolo Pattacini
Journal:  Breast Cancer Res       Date:  2017-09-11       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.